Cholangiocarcinoma — evolving concepts and therapeutic strategies

Ilyas, Sumera I., Khan, Shahid A., Hallemeier, Christopher L., Kelley, Robin K., Gores, Gregory J.·2018·Nature Reviews Clinical Oncology
DOI 10.1038/nrclinonc.2017.157

Cited by (1,001)

Items 401–500 of 1,001

  1. New systemic treatment options for advanced cholangiocarcinoma
    Valentina Zanuso, Giulia Tesini, Elena Valenzi, Lorenza Rimassa · 2024 · Journal of Liver Cancer
  2. Prognostic and Clinicopathological Significance of PD-L1 in Patients with Cholangiocarcinoma: A Meta-Analysis
    Qinfen Xie, Lidong Wang, Shusen Zheng · 2020 · Disease Markers
  3. Skeletal-muscle index predicts survival after percutaneous transhepatic biliary drainage for obstructive jaundice due to perihilar cholangiocarcinoma
    Jin-Xing Zhang, Ding Ye, Hai‐Tao Yan, Chun‐Gao Zhou, Jin Liu, Sheng Liu, Qing‐Quan Zu, Hai‐Bin Shi · 2020 · Surgical Endoscopy
  4. Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection
    Hu Liu, Guoteng Qiu, Fengjuan Hu, Hong Mei Wu · 2021 · World Journal of Surgical Oncology
  5. Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations
    Soravis Alm Osataphan, Treerat Mahankasuwan, Charupong Saengboonmee · 2021 · Journal of Hepato-Biliary-Pancreatic Sciences
  6. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma
    Yi Bai, Wen Tong, Fucun Xie, Liuyang Zhu, Hao Wu, Rui Shi, Lianjiang Wang, Long Yang, Zhisong Liu, Fei Miao et al. · 2021 · Aging
  7. Spatially-resolved transcriptomics analyses of invasive fronts in solid tumors
    Liang Li Wu, Jiayan Yan, Yinqi Bai, Feiyu Chen, Jiangshan Xu, Xuanxuan Zou, Ao Huang, Liangzhen Hou, Yu Zhong, Zehua Jing et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Plasma proteome plus site‐specific N‐glycoprofiling for hepatobiliary carcinomas
    Ting‐Tsung Chang, Ji‐Hong Cheng, Hung‐Wen Tsai, Kung‐Chia Young, Sun‐Yuan Hsieh, Cheng‐Hsun Ho · 2019 · The Journal of Pathology Clinical Research
  9. Assessment of the Outcomes of Intrahepatic Cholangiocarcinoma After Ultrasound-Guided Percutaneous Microwave Ablation Based on Albumin–Bilirubin Grade
    Hongcai Yang, Zhigang Cheng, Zhiyu Han, Fangyi Liu, Xiaoling Yu, Jie Yu, Ping Liang · 2020 · CardioVascular and Interventional Radiology
  10. Advances in the management of cholangiocarcinoma
    Andreas Giovanni Zori, Dennis J. Yang, Peter Vassilev Draganov, Roniel Cabrera · 2021 · World Journal of Hepatology
  11. Homophilic Interaction of CD147 Promotes IL-6-Mediated Cholangiocarcinoma Invasion via the NF-κB-Dependent Pathway
    Paweena Dana, Ryusho Kariya, Worachart Lert-itthiporn, Wunchana Seubwai, Saowaluk Saisomboon, Chaisiri Wongkham, Seiji Okada, Sopit Wongkham, Kulthida Vaeteewoottacharn · 2021 · International Journal of Molecular Sciences
  12. Prognostic impact of the metastatic lymph node number in intrahepatic cholangiocarcinoma
    Sung Hyun Kim, Dai Hoon Han, Gi Hong Choi, Jin Sub Choi, Kyung Sik Kim · 2022 · Surgery
  13. Optimizing the Diagnosis and Biomarker Testing for Patients with Intrahepatic Cholangiocarcinoma: A Multidisciplinary Approach
    May Thet Cho, Sepideh Gholami, Dorina Gui, Sooraj Tejaswi, Ghaneh Fananapazir, Nadine Abi‐Jaoudeh, Zeljka Jutric, Jason Samarasena, Xiaodong Li, Jennifer Brooke Valerin et al. · 2022 · Cancers
  14. Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management
    Sakti Chakrabarti, Heidi Diann Finnes, Amit Mahipal · 2022 · Expert Opinion on Drug Metabolism & Toxicology
  15. Use of the Advanced Lung Cancer Inflammation Index as a Prognostic Indicator for Patients With Cholangiocarcinoma
    Huasheng Wu, Fadian Ding, Meitai Lin, Zheng Shi, Zhengzhou Mei, Shaoqin Chen, Chao Jiang, Huabin Qiu, Zhenhua Zheng, Youting Chen et al. · 2022 · Frontiers in Surgery
  16. PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies
    Bhasker Rao Koppula, G Fine, Ahmed Ebada Salem, Matthew F. Covington, Richard H. Wiggins, John M. Hoffman, Kathryn A. Morton · 2022 · Cancers
  17. Mutational Impacts on the N and C Terminal Domains of the MUC5B Protein: A Transcriptomics and Structural Biology Study
    Aamir Mehmood, Sadia Nawab, Yifan Jin, Aman Chandra Kaushik, Dong‐Qing Wei · 2023 · ACS Omega
  18. NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
    Jijun Shan, Wangjie Jiang, Jiang Chang, Tao You Zhou, Yananlan Chen, Yaodong Zhang, Jifei Wang, Yuming Wang, Yirui Wang, Xiao Li Xu et al. · 2023 · International Journal of Biological Sciences
  19. 68Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma
    Zeyu Zhang, Chao Cheng, Hui Jiang, Guixia Pan, Yong Yu, Gang Jin, Changjing Zuo · 2024 · Clinical Nuclear Medicine
  20. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR ‐186‐5p/ PTP4A1 axis in cholangiocarcinoma
    Ou Li, Bo Jiang, Weimin Yi, Yu Zhang, Pin‐Zhou Yang, Chao Guo, Zengpeng Sun, Chuang Peng · 2021 · The Kaohsiung Journal of Medical Sciences
  21. The prognostic value of sarcopenia combined with preoperative fibrinogen–albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study
    Haitao Yu, Mingxun Wang, Yi Wang, Jinhuan Yang, Liming Deng, Wenming Bao, Bangjie He, Zixia Lin, Ziyan Chen, Kaiyu Chen et al. · 2021 · Cancer Medicine
  22. Vascular Involvements in Cholangiocarcinoma: Tips and Tricks
    Roberta Angelico, Bruno Sensi, Alessandro Parente, Leandro Siragusa, Carlo Gazia, Giuseppe Tisone, Tommaso Maria Manzia · 2021 · Cancers
  23. A systematic review of intraluminal high dose rate brachytherapy in the management of malignant biliary tract obstruction and cholangiocarcinoma
    Amandeep Singh Taggar, Paveen Mann, Michael Ryan Folkert, Shahdrad Aliakbari, Sten D. Myrehaug, Laura Ann Dawson · 2021 · Radiotherapy and Oncology
  24. [Translation and validation of the Revised Social Anhedonia Scale (SAS Social Anhedonia Scale, M.L. Eckblad, L.J. Chapman et al., 1982). Study of the internal and concurrent validity in 126 normal subjects].
    C. Kosmadakis, Catherine Bungener, A. Pierson, Roland Jouvent, Daniel Widlöcher · 1995 · PubMed
  25. Integrative Analysis of Intrahepatic Cholangiocarcinoma Subtypes for Improved Patient Stratification: Clinical, Pathological, and Radiological Considerations
    Tiemo Sven Gerber, Lukáš Müller, F. Bartsch, Lisa-Katharina Gröger, Mario Schindeldecker, Dirk Andreas Ridder, Benjamin Frank Goeppert, Markus Möhler, Christoph Dueber, Hauke Lang et al. · 2022 · Cancers
  26. Characteristics of bile microbiota in cholelithiasis, perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer.
    Zhengqi Li, Jiangtao Chu, Feixiong Su, Xuan Ding, Yueming Zhang, Lizhou Dou, Yong Liu, Ke Yan, Xudong Liu, Yumeng Liu et al. · 2022 · PubMed Central
  27. Clinical impact of bile‐derived exosomal microRNAs as novel diagnostic and prognostic biomarkers for biliary tract cancers
    Michihiro Yoshida, Hiroshi Yukawa, Kazuki Hayashi, Itaru Naitoh, Katsuyuki Miyabe, Yasuki Hori, Makoto Natsume, Naruomi Jinno, Akihisa Kato, Kenta Kachi et al. · 2022 · Cancer Science
  28. Prognostic value of lymphadenectomy in node-negative intrahepatic cholangiocarcinoma: A multicenter, retrospectively study
    Chen Chen, Jingbo Su, Hong Mei Wu, Yinghe Qiu, Tianqiang Song, Xianhan Mao, Yu He, Zhangjun Cheng, Wenlong Zhai, Jingdong Li et al. · 2022 · European Journal of Surgical Oncology
  29. Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression
    Zeyu Wei, Yijia Shi, Changning Xue, Mengna Li, Jianxia Wei, Guiyuan Li, Wei Xiong, Ming Zhou · 2022 · Journal of Cancer
  30. Role of radiofrequency ablation in advanced malignant hilar biliary obstruction
    Mamoru Takenaka, Tae Hoon Lee · 2023 · Clinical Endoscopy
  31. Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Hepatocellular Carcinoma ≤5 cm: Biological Characteristics and Patient Outcomes
    Wenjia Cai, Minghua Ying, Rongqin Zheng, Jintang Liao, Baoming Luo, Lina Tang, Wen Cheng, Hong Yang, Wei An, Yilin Yang et al. · 2023 · Liver Cancer
  32. Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts
    Naomi Yoshuantari, Yung‐Ming Jeng, Jau‐Yu Liau, Chia‐Hsiang Lee, Jia‐Huei Tsai · 2023 · Modern Pathology
  33. Unsupervised dimensionality reduction of medical hyperspectral imagery in tensor space
    Hongmin Gao, Meiling Wang, Xinyu Sun, Xueying Cao, Chenming Li, Qin Liu, Peipei Xu · 2023 · Computer Methods and Programs in Biomedicine
  34. Non-Coding RNA in Cholangiocarcinoma: An Update
    Jiehan Li, Haolin Bao, Ziyue Huang, Zixin Liang, Ning Lin, Chunjie Ni, Yi Xu · 2023 · Frontiers in Bioscience-Landmark
  35. The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma
    Fabio Bagante, Katiuscha Merath, Malcolm Hart Squires, Matthew John Weiss, Sorin Tiberiu Alexandrescu, Hugo P. Marques, Luca Antonio Aldrighetti, Shishir Kumar Maithel, Carlo Pulitanò, Todd W. Bauer et al. · 2018 · Journal of Gastrointestinal Surgery
  36. Proteomic Landscape of Cholangiocarcinomas Reveals Three Different Subgroups According to Their Localization and the Aspect of Non‐Tumor Liver
    Julie Le Faouder, Elia Gigante, Thibaut Léger, Miguel Albuquerque, Aurélie Bèaufrere, Olivier Soubrane, Safi Dokmak, Jean‐Michel Camadro, Jerome F. Cros, Valérie Paradis · 2018 · PROTEOMICS - CLINICAL APPLICATIONS
  37. Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors
    Olga Yu. Burenina, Natalia L. Lazarevich, Кустова Инна Феликсовна, Daria A. Shavochkina, Мороз Екатерина Анатольевна, Н. Е. Кудашкин, Yuriy I. Patyutko, Метелин Алексей Владимирович, Eduard F. Kim, Dmitry Aleksandrovich Skvortsov et al. · 2020 · Journal of Cancer Research and Clinical Oncology
  38. Comparison of the efficacy and safety among apatinib plus drug-eluting bead transarterial chemoembolization (TACE), apatinib plus conventional TACE and apatinib alone in advanced intrahepatic cholangiocarcinoma.
    Yubin Hu, Mingzhi Hao, Qizhong Chen, Zhangxian Chen, Hailan Lin · 2020 · PubMed Central
  39. Novel miRNA Predicts Survival and Prognosis of Cholangiocarcinoma Based on RNA‐seq Data and In Vitro Experiments
    Yuan Yao, Jiao Dechao, Zaoqu Liu, Jianjian Chen, Xueliang Zhou, Zhaonan Li, Jing Li, Xinwei Han · 2020 · BioMed Research International
  40. Immunotherapy in cholangiocarcinoma
    Raed Moh’d Taiseer Al-Rajabi, Weijing Sun · 2021 · Current Opinion in Gastroenterology
  41. Derazantinib: an investigational drug for the treatment of cholangiocarcinoma
    Stephan Braun, Paul M.J. McSheehy, Karine Litherland, Phil McKernan, Nicole Forster-Gross, Felix Bachmann, Mahmoud El‐Shemerly, Miryana Dimova-Dobreva, Inessa Polyakova, Manuel Häckl et al. · 2021 · Expert Opinion on Investigational Drugs
  42. Development and Validation of a Radiomic-Based Model for Prediction of Intrahepatic Cholangiocarcinoma in Patients With Intrahepatic Lithiasis Complicated by Imagologically Diagnosed Mass
    Beihui Xue, Sunjie Wu, Ming‐Hua Zheng, Huanchang Jiang, Jun Chen, Zhenghao Jiang, Tian Tian, Yifan Tu, Huanhu Zhao, Xian Shen et al. · 2021 · Frontiers in Oncology
  43. Responsibilities toward the coming generation forming a new creed
    Patrizia Lombardi · 2001 · PORTO@Iris
  44. Reprogramming of fatty acid metabolism: a hidden force regulating the occurrence and progression of cholangiocarcinoma
    Jinglei Zhang, Kaiyi Ruan, Zhuohuan Chu, Xiang Wang, Ye Gu, Hangbin Jin, Xiaofeng Zhang, Qiang Liu, Jianfeng Yang · 2025 · Cell Death Discovery
  45. Huaier Restrains Cholangiocarcinoma Progression in vitro and in vivo Through Modulating lncRNA TP73-AS1 and Inducing Oxidative Stress
    Daolin Ji, Wangyang Zheng, Peng Huang, Yue Yao, Xiangyu Zhong, Pengcheng Kang, Zhidong Wang, Guojing Shi, Yi Xu, Yunfu Cui · 2020 · OncoTargets and Therapy
  46. The Emerging Role of Ferroptosis in Liver Cancers
    Arianna Casini, Stefano Leone, Rosa Vaccaro, Giorgio Vivacqua, Ludovica Ceci, Luigi Pannarale, Antonio Franchitto, Paolo Onori, Eugenio Gaudio, Romina Mancinelli · 2022 · Life
  47. Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma
    Zhenyun Yang, Deyao Zhang, Xiaoxian Sima, Yizhen Fu, Huilan Zeng, Zili Hu, Jingyu Hou, Yangxun Pan, Yaojun Zhang, Zhongguo Zhou et al. · 2023 · International Immunopharmacology
  48. Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma
    Apiwit Sae-Fung, Apiwat Mutirangura, Siriporn Jitkaew · 2023 · Frontiers in Immunology
  49. Non-Inflamed Tumor Microenvironment and Methylation/Downregulation of Antigen-Presenting Machineries in Cholangiocarcinoma
    Naoshi Nishida, Tomoko Aoki, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Masatoshi Kudo · 2023 · Cancers
  50. Radiomics using CT images for preoperative prediction of lymph node metastasis in perihilar cholangiocarcinoma: a multi-centric study
    Pengchao Zhan, Ting Yang, Yuan Zhang, Ke-yan Liu, Zhen Li, Yuyuan Zhang, Xing Liu, Nana Liu, Huixia Wang, Bo Z. Shang et al. · 2023 · European Radiology
  51. Mitochondrial transplantation inhibits cholangiocarcinoma cells growth by balancing oxidative stress tolerance through PTEN/PI3K/AKT signaling pathway
    Xiaocong Liu, Yuanyuan Zhang, Xiaoyan Yang, Yan Zhang, Yulan Liu, Li Wang, Ting Yi, Jing Yuan, Wen Wu, Yi Jian · 2023 · Tissue and Cell
  52. The dark side of SIRT7
    Francisco Alejandro Lagunas‐Rangel · 2023 · Molecular and Cellular Biochemistry
  53. Analysis of PD-1 related immune transcriptional profile in different cancer types
    Jun Shang, Qian Song, Zuyi Yang, Xiaoyan Sun, Meijuan Xue, Wenjie Chen, Jingcheng Yang, Sihua Wang · 2018 · Cancer Cell International
  54. MicroRNA‑137 suppresses the proliferation, migration and invasion of cholangiocarcinoma cells by targeting WNT2B
    Tengxiang Chen, Shan Lei, Zhirui Zeng, Shutao Pan, Jinjuan Zhang, Yan Xue, Yuanmei Sun, Jinzhi Lan, Su Xu, Dahua Mao et al. · 2020 · International Journal of Molecular Medicine
  55. Cholangiocarcinoma as an Indication for Liver Transplantation in the Era of Transplant Oncology
    Enrico Gringeri, Martina Gambato, Gonzalo Sapisochín, Tommy Ivanics, Erica Nicola Lynch, Claudia Mescoli, Patrizia Burra, Umberto Cillo, Francesco Paolo Russo · 2020 · Journal of Clinical Medicine
  56. Describing Treatment Patterns for Elderly Patients with Intrahepatic Cholangiocarcinoma and Predicting Prognosis by a Validated Model: A Population-Based Study
    Hanlong Zhu, Kun Ji, Wei Wu, Si Zhao, Jian Zhou, Chunmei Zhang, Ruiyi Tang, Lin Miao · 2021 · Journal of Cancer
  57. Novel Pharmacological Options in the Treatment of Cholangiocarcinoma: Mechanisms of Resistance
    José J.G. Marı́n, Paula Sanchon-Sanchez, Candela Cives-Losada, Sofía del Carmen, Jesús Manuel González Santiago, María Jesús Monte, Rocı́o I.R. Macı́as · 2021 · Cancers
  58. Downregulation of MCM8 expression restrains the malignant progression of cholangiocarcinoma
    Jingcheng Hao, Haimin Deng, Yang Yuan, Lidan Chen, Qiang Wu, Pei Yao, Junen Li, Bowen Li, Xueli Jin, Haiqing Wang et al. · 2021 · Oncology Reports
  59. The Role of the Hedgehog Pathway in Cholangiocarcinoma
    Giulia Anichini, Laura Carrassa, Barbara A. Stecca, Fabio Marra, Chiara Raggi · 2021 · Cancers
  60. Targeting GPX4 to Induce Ferroptosis Overcomes Chemoresistance Mediated by the PAX8‐AS1 /GPX4 Axis in Intrahepatic Cholangiocarcinoma
    Zhi‐Wen Chen, Jijun Shan, Mo Chen, Zong Wu, Yiming Zhao, Hongxu Zhu, Xin Jin, Yi‐Xiu Wang, Yibin Wu, Zhen Xiang et al. · 2025 · Advanced Science
  61. High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China
    Yanhang Gao, Yanqing Li, Xiaowen Liu, Tong Zhang, Ge Yu, Yang Wang, Ying Shi, Xiumei Chi, Xiaomei Wang, Xiuzhu Gao et al. · 2020 · Scientific Reports
  62. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma
    Thanpisit Lomphithak, Swati Choksi, Apiwat Mutirangura, Rutaiwan Tohtong, Tewin Tencomnao, Hajime Usubuchi, Michiaki Unno, Hironobu Sasano, Siriporn Jitkaew · 2020 · Cell Communication and Signaling
  63. Lymphoepithelioma‐like neoplasm of the biliary tract with ‘probable low malignant potential’
    Binny Khandakar, Junru Liu, Swan N. Thung, Ying Li, Hyungjin Rhee, Alexander C. Kagen, Tommy Richard Sun-wing Tong, Young Nyun Park, Neil David Theise, Irene Oi‐Lin Ng · 2021 · Histopathology
  64. Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract Cancer
    Savannah S. Liddell, Sakti Chakrabarti, Grant A. Wintheiser, Tyler Zemla, Qian Shi, Sri Harsha Tella, Zhaohui Jin, Vanessa Wookey, Hind Hassan, Nguyen H. Tran et al. · 2022 · JCO Precision Oncology
  65. CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
    Tatjana Arsenijevic, Katia Coulonval, Eric Raspé, Anne Demols, Pierre P. Roger, Jean‐Luc Van Laethem · 2023 · Cancers
  66. Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
    Αναστάσιος Γκουντάκος, Filippo Maria Martelli, Nicola Silvestris, Michele Bevere, Mario De Bellis, Laura Alaimo, Elena Sapuppo, Francesca Masetto, Aldo Mombello, Michele Simbolo et al. · 2023 · Cancers
  67. Tumor-Infiltrating B Lymphocytes: Promising Immunotherapeutic Targets for Primary Liver Cancer Treatment
    Giulia Milardi, Ana Lleò · 2023 · Cancers
  68. AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
    Liming Deng, Wenming Bao, Baofu Zhang, Sina Zhang, Ziyan Chen, Xuewen Zhu, Bangjie He, Lijun Wu, Xiaohu Chen, Tuo Deng et al. · 2023 · Cell Death and Disease
  69. m6A methylation modification and immune cell infiltration: implications for targeting the catalytic subunit m6A-METTL complex in gastrointestinal cancer immunotherapy
    Peng Chen, Fen Xiong, Xi Pu, Zhangmin Hu, Yufei Yang, Xuehan Qiao, Yuchun Jiang, Miao Han, Deqiang Wang, Xiaoqin Li · 2023 · Frontiers in Immunology
  70. Neuroendocrine carcinoma in the extrahepatic biliary tract
    Liang Zhang, Dalong Wan, Li Bao, Qing Chen, Haiyang Xie, Shiguo Xu, Sheng‐Zhang Lin · 2018 · Medicine
  71. Long non‐coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR‐551b‐3p/CCND1 axis
    Weiping Chang, Yuan Wang, Wenzhi Li, Zhimin Geng · 2020 · Clinical and Experimental Pharmacology and Physiology
  72. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection
    Jinju Wang, Hui Li, Jiaxin Li, Xu Lin, Hong Yan Wu, Yong Zeng · 2020 · World Journal of Gastroenterology
  73. Olaparib and Pembrolizumab Treatment for BRCA1-Mutated and PD-L1-Positive Intrahepatic Cholangiocarcinoma Recurrence and Metastasis: A Case Report
    Fan Xiong, Jing Gong, Qi Wang · 2020 · OncoTargets and Therapy
  74. Integrating Machine Learning and Tumor Immune Signature to Predict Oncologic Outcomes in Resected Biliary Tract Cancer
    Gu‐Wei Ji, Ke Wang, Yongxiang Xia, Jinsong Wang, Xuehao Wang, Xiangcheng Li · 2020 · Annals of Surgical Oncology
  75. Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions
    Alessandro Rizzo, Giovanni Brandi · 2021 · Cancer Treatment and Research Communications
  76. Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview Study
    Nikunj Ramanikbhai Patel, Xandra Lie, Chad J. Gwaltney, Nana Rokutanda, Afsaneh Barzi, Davide Melisi, Teresa Mercade Macarulla, Makoto Ueno, Seung Tae Kim, Oren I. Meyers et al. · 2021 · Oncology and Therapy
  77. The Presence of Small Nerve Fibers in the Tumor Microenvironment as Predictive Biomarker of Oncological Outcome Following Partial Hepatectomy for Intrahepatic Cholangiocarcinoma
    Jan Bednarsch, Xiuxiang Tan, Zoltán Czigány, Dong Liu, Sven Arke Lang, Shivan Sivakumar, Jakob Nikolas Kather, Simone Appinger, Mika Rosin, Shiva Boroojerdi et al. · 2021 · Cancers
  78. Prodigiosin inhibits cholangiocarcinoma cell proliferation and induces apoptosis via suppressing SNAREs-dependent autophagy
    Dijie Zheng, Shiyu Chen, Kun Cai, Linhan Lei, Chunchen Wu, Chengyi Sun, Yazhu Deng, Yu Chao · 2021 · Cancer Cell International
  79. A comparative study of efficacy and safety of transarterial chemoembolization with CalliSpheres and conventional transarterial chemoembolization in treating unresectable intrahepatic cholangiocarcinoma patients
    Tao Sun, Weihua Zhang, Lei Chen, Yanqiao Ren, Yiming Liu, Chuansheng Zheng · 2022 · Journal of Cancer
  80. FUT8 is regulated by miR‐122‐5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling
    Fanghua Chen, Yin Li, Ling Aye, Yingcheng Charles Wu, Liangqing Dong, Zijian Yang, Qiang Gao, Shu Zhang · 2022 · Cellular Oncology
  81. Inhibition of KLHL21 prevents cholangiocarcinoma progression through regulating cell proliferation and motility, arresting cell cycle and reducing Erk activation
    Jian Chen, Wenfeng Song, Yehui Du, Zequn Li, Zefeng Xuan, Long Zhao, Jun Chen, Yongchao Zhao, Biguang Tuo, Shusen Zheng et al. · 2018 · Biochemical and Biophysical Research Communications
  82. Functions of METTL1/WDR4 and QKI as m7G modification - related enzymes in digestive diseases
    Wenyan Zhou, Yan Yi, Wenyu Cao, Xiaolin Zhong, Ling Chen · 2025 · Frontiers in Pharmacology
  83. Artificial Intelligence and Radiomics in Cholangiocarcinoma: A Comprehensive Review
    Marta Zerunian, Tiziano Polidori, Federica Palmeri, Stefano Nardacci, Antonella Del Gaudio, Benedetta Masci, Giuseppe Tremamunno, Michela Polici, Domenico De Santis, Francesco Pucciarelli et al. · 2025 · Diagnostics
  84. Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics
    Xiaowen Cui, Teng Huang, Tianyi Jiang, Hongyang Wang · 2025 · Cancer Letters
  85. MEK inhibition suppresses K-Ras wild-type cholangiocarcinoma in vitro and in vivo via inhibiting cell proliferation and modulating tumor microenvironment
    Pan Wang, Xinhua Song, Kirsten Utpatel, Runze Shang, Yoon Mee Yang, Meng Michelle Xu, Jie Zhang, Li Che, John Dozier Gordan, Antonio Cigliano et al. · 2019 · Cell Death and Disease
  86. Burden of illness for patients with cholangiocarcinoma in the United States: a retrospective claims analysis
    Christina X. Chamberlain, Elizabeth Faust, Debbie Goldschmidt, Nathan Webster, Audra N. Boscoe, Dendy S. Macaulay, Mary Linton B. Peters · 2021 · Journal of Gastrointestinal Oncology
  87. Proteomic analysis identifies deregulated metabolic and oxidative-associated proteins in Italian intrahepatic cholangiocarcinoma patients
    Giuliana Cavalloni, Caterina Peraldo Neia, Annamaria Massa, Carlo M. Bergamini, Alessandro Trentini, Gaetano De Rosa, Lorenzo Daniele, Fabiola Ciccosanti, Carlo Cervellati, Francesco Leone et al. · 2021 · BMC Cancer
  88. Radiomics of Biliary Tumors: A Systematic Review of Current Evidence
    Francesco Fiz, Visala S Jayakody Arachchige, Matteo Gionso, Ilaria Pecorella, Apoorva Selvam, Dakota Russell Wheeler, Martina Sollini, Luca Viganò · 2022 · Diagnostics
  89. Molecular diagnosis of pancreatobiliary tract cancer by detecting mutations and methylation changes in bile samples
    Shun He, Fanxin Zeng, Huihui Yin, Pei Wang, Yinlei Bai, Qianqian Song, Jiangtao Chu, Zhen Kun Huang, Yumeng Liu, Hong Liu et al. · 2022 · EClinicalMedicine
  90. Intra-Tumoral Secondary Follicle-like Tertiary Lymphoid Structures Are Associated with a Superior Prognosis of Overall Survival of Perihilar Cholangiocarcinoma
    Fa-Peng Zhang, Ke Zhu, Taifeng Zhu, Chaoqun Liu, ZHANG HONG-HUA, Lei-bo Xu, Gang Xiao, Chao Liu · 2022 · Cancers
  91. MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration
    Jun Wu, Yang Guo, Zhifan Zuo, Ziwei Zhu, Lei Han · 2023 · World Journal of Gastroenterology
  92. PTPN9 dephosphorylates FGFR2pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma
    Li-ming Zhao, Jia-Liang Liu, Kangshuai Li, Chao Zhang, Tian-Li Chen, Zengli Liu, Yongchang Tang, Xiaoqiang Hu, An-da Shi, Lizhuang Shu et al. · 2023 · Hepatology
  93. The role and implication of autophagy in cholangiocarcinoma
    Hayat Khizar, Yufei Hu, Yanhua Wu, Jianfeng Yang · 2023 · Cell Death Discovery
  94. Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma
    Sridhar Mishra, Pallavi Srivastava, Anshuman Pandey, Saumya Shukla, Akash Agarwal, Nuzhat Husain · 2023 · Laboratory Investigation
  95. Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging
    Jiong Liu, Jian Shu · 2024 · Critical Reviews in Oncology/Hematology
  96. NEDD4 and NEDD4L: Ubiquitin Ligases Closely Related to Digestive Diseases
    Jiafan Xu, Wang Jiang, Tian Hu, Yan Long, Yueming Shen · 2024 · Biomolecules
  97. PIWI-interacting RNAs (PiRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: A comprehensive review
    Sahar Ahmadi Asouri, Esmat Aghadavod, Hamed Mirzaei, Alireza Abaspour, Mohammad Esmaeil Shahaboddin · 2024 · Heliyon
  98. An analysis of the global burden of gallbladder and biliary tract cancer attributable to high BMI in 204 countries and territories: 1990–2021
    Zhiping Hu, Xue Bing Wang, Xin Zhang, Wuping Sun, Jun Mao · 2024 · Frontiers in Nutrition
  99. Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging
    M. Baretti, Soumya Shekhar, V. Sahai, Daniel H. Shu, Kathryn Howe, Valerie Gunchick, N. Assarzadegan, Emma Kartalia, Qingfeng Zhu, E. Hallab et al. · 2025 · Hepatology Communications
  100. Prognostic biomarkers for cholangiocarcinoma and their clinical implications
    Charupong Saengboonmee, Kanlayanee Sawanyawisuth, Yaovalux Chamgramol, Sopit Wongkham · 2018 · Expert Review of Anticancer Therapy